共 50 条
- [1] Efficacy and safety of PD-L1 inhibitors versus PD-1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancerCANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (03) : 637 - 644Yu, HuiChen, PingCai, XiuyuChen, ChenZhang, XuanyeHe, LinaZhou, YixinHong, ShaodongZhang, Bei
- [2] Updated Bayesian network meta-analysis on the efficacy and safety of PD-1 versus PD-L1 inhibitors in first-line treatment with chemotherapy for extensive-stage small-cell lung cancerFRONTIERS IN ONCOLOGY, 2025, 14Wang, KeZheng, ChuangjieChen, XinrongLin, PenghuiLin, MenggeChen, CuizhenZhai, Linzhu
- [3] Efficacy and Safety of PD-L1 Inhibitors plus Chemotherapy versus Chemotherapy Alone in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer: A Retrospective Real-World StudyJOURNAL OF ONCOLOGY, 2022, 2022Qu, JingjingKalyani, Farhin ShaheedShen, QianYang, GuangdieCheng, TianliLiu, LiZhou, JianyaZhou, Jianying
- [4] Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysisBMC Cancer, 23Yanrong WangLingling LiJia HuYan ZhaoHuan YanMing GaoXuejiao YangXia ZhangJunxun MaGuanghai Dai
- [5] Comparison of efficacy and safety between PD-1 inhibitors and PD-L1 inhibitors plus platinum-etoposide as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, real-world analysisBMC CANCER, 2023, 23 (01)Wang, YanrongLi, LinglingHu, JiaZhao, YanYan, HuanGao, MingYang, XuejiaoZhang, XiaMa, JunxunDai, Guanghai
- [6] Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysisTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15Li, HuijuanHan, HedongLi, ChulingWu, RanpuWang, ZhaofengWang, YiminZhan, PingLv, TangfengZhang, FangSong, YongLiu, Hongbing
- [7] Which Is More Suitable for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer, PD-L1 Inhibitors Versus PD-1 Inhibitors? A Systematic Review and Network Meta-AnalysisCLINICAL RESPIRATORY JOURNAL, 2024, 18 (07):Liu, WenjingYu, LulinFeng, YuqianHuang, SiyuHua, YuxinPeng, MingyingRuan, ShanmingZhang, Kai
- [8] Efficacy and safety of PD-1/PD-L1 inhibitor plus chemotherapy versus chemotherapy alone as first-line treatment for extensive-stage small cell lung cancer: A systematic review and meta-analysisTHORACIC CANCER, 2020, 11 (12) : 3536 - 3546Zhang, ShuangLi, ShuangCheng, Ying
- [9] fficacy and safety comparison of PD-1 inhibitors vs. PD-L1 inhibitors in extensive-stage small-cell lung cancer: a retrospective comparative cohort studyJOURNAL OF THORACIC DISEASE, 2022, 14 (12) : 4925 - 4937Yang, GuanghuiSun, HongfuSun, NiniHuang, WeiWang, ZhongtangZhang, HuaweiLiu, Chengxin
- [10] Comparison of the Efficacy and Safety of PD-1/PD-L1 Inhibitors in the Treatment of Small Cell Lung CancerCANCER REPORTS, 2025, 8 (01)Zhang, QichenHan, XiaojuanLiu, JiayiQiao, Hui